Clinical Ink develops electronic documents recording software for recording source data on mobile devices during clinical trials. Founded by Doug Pierce and Tommy Littlejohn in 2006, Clinical Ink is backed by investors that include MPM Capital, Silicon Valley Bank, McKesson Ventures, RTI International, Novaquest Capital Management and is headquartered in Winston Salem.